menu

IV Flush Syringe Market

Schedule Call

IV Flush Syringe Market

IV Flush Syringe Market by Type (Saline IV Flush Syringe and Heparin IV Flush Syringe), by Application (Cardiac Diseases, Rheumatoid Arthritis, Diabetes, Cancer, and Others), by End User (Hospitals, Ambulatory Surgical Centers, Clinics, and Others) - Global Outlook & Forecast 2022-2030

GR - 570518 Category: Medical Devices

Number of pages: 100  |  Report Format: PDF  |  Published date: 17 January, 2023

Historical Years – 2020  |  Base Year – 2021  |  Forecasted Years – 2022-2030


IV Flush Syringe Market Scope

Report Attribute

Details

Market size value in 2021

US$ 293. 23 million

Revenue forecast in 2030

US$ 472.34 million

Growth Rate

CAGR of 5.40% from 2022 to 2030

Base year for estimation

2021

Historical Years

2020

Forecast period

2022-2030

Segments covered

Type, Application, End User, and Region.

Regional scope

North America, Europe, Asia Pacific, and the Rest of the World (ROW)

Report Overview

According to the deep-dive market assessment study conducted by Growth Plus Reports, the global IV flush syringe was pegged at US$ 293. 23 million in 2021 and is expected to register a revenue CAGR of 5.40% to reach US$ 472.34 million by 2030.

Market Fundamentals

IV flush syringes are medical devices that are used to clear intravenous pathways and prevent blockage formation in veins. IV flush syringes clear the intravenous path so that every drop of medication reaches its active sites to get absorbed completely, and help in avoiding drug mixing inside the tube.  IV flush syringes are classified into saline and heparin. Saline IV flush syringe is used to clear and sterile the intravenous path for drug travel. A heparin IV flush syringe is an anticoagulant, used before angioplasty and catheter insertion, which helps prevent blockage in arteries.

[465465498]

Market Dynamics

The global IV flush syringe market is driven by the increasing prevalence of chronic diseases such as diabetes, cardiovascular diseases, autoimmune disease, arthritis, and cancer. Additionally, avoiding drug mixing, ensuring patient safety, and increasing regulation of healthcare practices are also fueling the global IV flush syringe market revenue growth. Moreover, the increasing number of key players and acquisitions & mergers are contributing to the revenue growth of the global IV flush syringe market. However, increasing recall and skilled person requirements for the administration of IV flush syringes are hindering the revenue growth of the global IV flush syringe market.

Market Ecosystem

The global IV Flush Syringe market has been analyzed from four perspectives: type, application, end-user, and region. 

IV Flush Syringe Market by Type

[654312]

Based on the type, the global IV flush syringe market is segmented into saline IV flush syringes and heparin IV flush syringes. 

The saline IV flush syringe segment dominates the global IV flush syringe market owing to the high prevalence of chronic diseases such as cardiovascular diseases, cancers, arthritis, etc., Furthermore, increasing patient hospitalization rates and multiple drug administration needs are also contributing to the revenue growth of the market.  Additionally, the introduction of new products and the high presence of key players are fueling the revenue growth of this segment. 

IV Flush Syringe Market by Application

Based on application, the global IV flush Syringe market is segmented into cardiac diseases, rheumatoid arthritis, diabetes, cancer, and others.

The cancer segment accounts for the largest revenue share in the global IV flush syringe market owing to the increasing prevalence of breast cancer, skin cancer, etc. Additionally, increasing awareness about cancer treatment, and the need for immediate medical attention & hospitalization are driving the revenue growth of the IV flush syringe market. In 2020, the National Cancer Institute stated that nearly 1,806,590 new cancer cases will be diagnosed and 606,520 people may die from cancer in the United States.

IV Flush Syringe Market by End-User

Based on end-user, the global IV flush syringe market is segmented into hospitals, ambulatory surgical centers, clinics, and others. 

The hospital segment dominates the global IV flush syringe market. This high revenue growth of the segment is attributed to the increasing prevalence of chronic diseases such as diabetes, cardiovascular diseases, etc. Additionally, growing numbers of hospitals, improving healthcare practices, and the introduction of new products are also contributing to the growth of the global IV flush syringe market revenue share.

IV Flush Syringe Market by Region

Based on region, the global IV flush syringe market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. 

North America dominates the global IV flush syringe market in terms of revenue share. The large revenue share of North America in the global market can be attributed to prevailing cancer and cardiac diseases in this region, developed infrastructure, and technological advancement. Additionally, the adoption of standard healthcare practices and increasing healthcare infrastructure are also contributing to the revenue growth of the IV flush syringe market. 

Competitive Landscape

The prominent players operating in the global IV flush syringe market are: 

Strategic Development

  • In March 2022, the Food and Drug Administration recommended strategies for healthcare providers to conserve prefilled 0.9% sodium chloride intravenous lock/flush syringes, which were in short supply due to increased demand during the COVID-19 public health emergency and challenging vendor supply chain. 

Frequently Asked Questions About This Report

North America accounts for the largest revenue share in the global IV flush syringe market.

The growing prevalence of chronic diseases, increasing awareness about patient safety, and rising numbers of key players are the key factors driving the global IV flush syringe market revenue growth.

The expected revenue CAGR for the global IV flush syringe market is 5.40% during the forecast period from 2022 to 2030.

The estimated market size of the global IV flush syringe market is US$ 472.80 million in 2030.

Aquabiliti, B. Braun Melsungen AG, Becton, Dickinson and Company, Cardinal Health, and Medefil, Inc., are among the key players in the global IV flush syringe industry.

Table of Content

  1. INTRODUCTION
    1. Market Ecosystem 
    2. Timeline Under Consideration
      1. Historical Years – 2020
      2. Base Year – 2021
      3. Forecasted Years – 2022 to 2030
    3. Currency Used in the Report
  2. RESEARCH METHODOLOGY 
    1. Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
    4. Market Estimation Approach
      1. Bottom Up 
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions       
  3. PREMIUM INSIGHTS
    1. Current Market Trends (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2021) 
  4. MARKET DYNAMICS
    1. Drivers
    2. Restraints/Challenges
    3. Opportunities
  5. GLOBAL IV FLUSH SYRINGE MARKET - ANALYSIS & FORECAST, BY TYPE
    1. Saline IV Flush Syringe
    2. Heparin IV Flush Syringe
  6. GLOBAL IV FLUSH SYRINGE MARKET - ANALYSIS & FORECAST, BY APPLICATION
    1. Cardiac Disease
    2. Rheumatoid Arthritis
    3. Diabetes
    4. Cancer 
    5. Others
  7. GLOBAL IV FLUSH SYRINGE MARKET - ANALYSIS & FORECAST, BY END USER
    1. Hospitals 
    2. Ambulatory Surgical Centers 
    3. Clinics
    4. Others
  8. GLOBAL IV FLUSH SYRINGE MARKET - ANALYSIS & FORECAST, BY REGION
    1. North America IV Flush Syringe Market
      1. North America IV Flush Syringe Market, by Type
      2. North America IV Flush Syringe Market, by Application
      3. North America IV Flush Syringe Market, by End User
      4. North America IV Flush Syringe Market, by Country
        1. U.S.
          1. U.S. IV Flush Syringe Market, by Type
          2. U.S. IV Flush Syringe Market, by Application
          3. U.S. IV Flush Syringe Market, by End User
        2. Canada
          1. Canada IV Flush Syringe Market, by Type
          2. Canada IV Flush Syringe Market, by Application
          3. Canada IV Flush Syringe Market, by End User
    2. Europe IV Flush Syringe Market
      1. Europe IV Flush Syringe Market, by Type
      2. Europe IV Flush Syringe Market, by Application
      3. Europe IV Flush Syringe Market, by End User
      4. Europe IV Flush Syringe Market, by Country/Region
        1. Germany
          1. Germany IV Flush Syringe Market, by Type
          2. Germany IV Flush Syringe Market, by Application
          3. Germany IV Flush Syringe Market, by End User
        2. U.K.
          1. U.K. IV Flush Syringe Market, by Type
          2. U.K. IV Flush Syringe Market, by Application
          3. U.K. IV Flush Syringe Market, by End User
        3. Spain
          1. Spain IV Flush Syringe Market, by Type
          2. Spain IV Flush Syringe Market, by Application
          3. Spain IV Flush Syringe Market, by End User
        4. Italy 
          1. Italy IV Flush Syringe Market, by Type
          2. Italy IV Flush Syringe Market, by Application
          3. Italy IV Flush Syringe Market, by End User
        5. France
          1. France IV Flush Syringe Market, by Type
          2. France IV Flush Syringe Market, by Application
          3. France IV Flush Syringe Market, by End User
        6. Rest of Europe 
          1. Rest of Europe IV Flush Syringe Market, by Type
          2. Rest of Europe IV Flush Syringe Market, by Application
          3. Rest of Europe IV Flush Syringe Market, by End User
    3. Asia Pacific IV Flush Syringe Market
      1. Asia Pacific IV Flush Syringe Market, by Type
      2. Asia Pacific IV Flush Syringe Market, by Application
      3. Asia Pacific IV Flush Syringe Market, by End User
      4. Asia Pacific IV Flush Syringe Market, by Country/Region
        1. China
          1. China IV Flush Syringe Market, by Type
          2. China IV Flush Syringe Market, by Application
          3. China IV Flush Syringe Market, by End User
        2. Japan
          1. Japan IV Flush Syringe Market, by Type
          2. Japan IV Flush Syringe Market, by Application
          3. Japan IV Flush Syringe Market, by End User
        3. India
          1. India IV Flush Syringe Market, by Type
          2. India IV Flush Syringe Market, by Application
          3. India IV Flush Syringe Market, by End User
        4. South Korea
          1. South Korea IV Flush Syringe Market, by Type
          2. South Korea IV Flush Syringe Market, by Application
          3. South Korea IV Flush Syringe Market, by End User
        5. Australia
          1. Australia IV Flush Syringe Market, by Type
          2. Australia IV Flush Syringe Market, by Application
          3. Australia IV Flush Syringe Market, by End User
        6. Rest of Asia Pacific 
          1. Rest of Asia Pacific IV Flush Syringe Market, by Type
          2. Rest of Asia Pacific IV Flush Syringe Market, by Application
          3. Rest of Asia Pacific IV Flush Syringe Market, by End User
    4. Rest of the World IV Flush Syringe Market
      1. Rest of the World IV Flush Syringe Market, by Type
      2. Rest of the World IV Flush Syringe Market, by Application
      3. Rest of the World IV Flush Syringe Market, by End User
      4. Rest of the World IV Flush Syringe Market, By Region
        1. Latin America
          1. Latin America IV Flush Syringe Market, by Type
          2. Latin America IV Flush Syringe Market, by Application
          3. Latin America IV Flush Syringe Market, by End User
        2. Middle East & Africa
          1. Middle East & Africa IV Flush Syringe Market, by Type
          2. Middle East & Africa IV Flush Syringe Market, by Application
          3. Middle East & Africa IV Flush Syringe Market, by End User
  9. COMPANY PROFILES        
    1. Aquabiliti
      1. Business Snapshot
      2. Products Offered
      3. Financial Details*
      4. Strategic Developments
    2. B. Braun Melsungen AG 
    3. Becton, Dickinson and Company
    4. Cardinal Health 
    5. Medefil, Inc.
    6. Medline Industries, LP
    7. Nipro Corporation
    8. Polymedicure 
    9. SteriCare Solutions 

*Insights on financial performance are subject to the availability of information in the public domains*


Single User License
Single User License
Multi User License
Enterprise User License
$4,750.00
Provides access to one user only and should not be shared with other employees within the organization.
Provides access to up to five users within the department or an organization.
Provides access to all the employees in the organization. The report can also be shared with subsidiaries, sister concerns and group entities.
Grants user/users’ access to quantitative data only, which includes but is not restricted to numeric data, tables, and charts as defined by Growth+ Reports.

Using the fundamental research and knowledge services capabilities of GRG Health, Growth Plus Reports may now be tailored based on client needs.

GRG Health's unique GrowthMIX strategy and comprehensive research methodology enable us to provide unique and valuable insights to our clients while uncovering trends that would not be discovered using traditional techniques.

sans

Snehal Deshmukh

Principle Consultant

Speak to analyst